This inventor holds 1 USPTO granted patent. Top assignee: Amneal Pharmaceuticals LLC. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Siddiqui Arif Badrulhusan: Innovator in Pharmaceutical Chemistry
Introduction
Siddiqui Arif Badrulhusan is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug preparation. His work is characterized by a focus on improving industrial feasibility and efficiency.
Latest Patents
Siddiqui holds a patent for a process for the preparation of saxagliptin and its hydrochloride salt. This patent describes an improved and industrially feasible method for synthesizing saxagliptin, along with novel intermediates that facilitate its production. The patent highlights the importance of innovation in the pharmaceutical industry, particularly in the development of effective medications.
Career Highlights
Siddiqui Arif Badrulhusan is currently associated with Amneal Pharmaceuticals LLC, a company known for its commitment to advancing healthcare through innovative solutions. His role at Amneal Pharmaceuticals allows him to apply his expertise in pharmaceutical chemistry to real-world challenges, contributing to the development of new therapeutic options.
Collaborations
Siddiqui has collaborated with notable colleagues, including Patil Shashikant Prabhakarrao and Pansuriya Ketan Jahyantibhai. These collaborations reflect a team-oriented approach to innovation, fostering an environment where ideas can be shared and developed.
Conclusion
Siddiqui Arif Badrulhusan exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the preparation of saxagliptin, underscore the importance of research and development in creating effective medications. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
